ReGelTec Overview
- Founded
- 2018
- Status
- Private
- Employees
- 11
- Latest Deal Type
- Series A2
- Investors
- 5
ReGelTec General Information
Description
Developer of a medical device designed for treating lower back pain and degenerative disc disease. The company's device is injected into the nucleus of an intervertebral disc with a small needle as a viscous solution that is filled to a predetermined height or pressure and forms a single solid implant within the disc as it cools to body temperature, enabling patients to reduce the pain without follow up surgery.
Contact Information
Website
www.regeltec.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
- 323 West Camden Street
- Suite 600
- Baltimore, MD 21201
- United States
+1 (443) 000-0000
ReGelTec Timeline
ReGelTec Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A2) | 15-Jun-2021 | 000 | Completed | Product Development | ||
| 2. Early Stage VC (Series A) | 13-Jan-2021 | 000 | 000 | 0000 | Completed | Product Development |
| 1. Seed Round | 28-Nov-2018 | $2M | $2M | 00.00 | Completed | Startup |
ReGelTec Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 000 | |
| Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
ReGelTec Patents
ReGelTec Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020205635-A1 | Hydrogels and method of making the same | Pending | 07-Jan-2019 | 000000000 | |
| CA-3125440-A1 | Hydrogels and method of making the same | Pending | 07-Jan-2019 | 000000000 | |
| US-20200255601-A1 | Hydrogels and method of making the same | Granted | 07-Jan-2019 | 000000000 | |
| US-10954347-B2 | Hydrogels and method of making the same | Active | 07-Jan-2019 | 000000000 | |
| US-10507264-B1 | Cross-linked hydrogels and method of making the same | Active | 07-Jan-2019 | A61L27/26 | 0 |
ReGelTec Executive Team (3)
ReGelTec Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Anthony Lowman Ph.D | ReGelTec | Co-Founder, Chief Technology Officer & Board Member | 000 0000 |
| Moss Amer | TEDCO | Board Member | 000 0000 |
ReGelTec Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialReGelTec Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| PTX Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Keiretsu Forum | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Tech Council Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| TEDCO | Venture Capital | Minority | 000 0000 | 000000 0 | |
| The Abell Foundation | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 |